Navigation Links
Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
Date:7/7/2010

vaccination coverage, 2004-08 103

Figure 49: Argentina: vaccination coverage by region, 2007 104

Figure 50: Argentina: key future target vaccine indications, 2010 112

To order this report:

Pharmaceutical Industry: Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email:

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
2. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
3. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
5. FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products
6. GHX Collaboration Portal Validates Contract Pricing in Real Time; First to be Used by All Stakeholders of the Healthcare Supply Chain
7. Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence
8. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
9. Concentra Offers Flu Vaccines to Keep America Working
10. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
11. 92 Medicines and Vaccines now in Development for HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
(Date:7/29/2015)... , July 29, 2015 The Judicial Panel ... week about whether to centralize Inferior vena cava (IVC) ... IVC manufacturer, Cook Medical, have already been centralized by ... implanted in patients at risk for a pulmonary embolism. ... traveling to the lungs. Claims against Bard and Cook ...
(Date:7/29/2015)... , July 29, 2015  ViaCyte, Inc., a privately-held regenerative ... the treatment of diabetes in clinical trials, today announced the opening ... ONE, or S afety, T olerability, and E ... Diabetes.  The new site, which is the first in ... Hospitals in Edmonton , Alberta.  ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4
... - Poster Presented at ASCO Annual Meeting ... CHICAGO, May 31 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. ... on oncology, today presented preliminary safety and,efficacy ... trial of picoplatin in,combination with docetaxel and ...
... 3 Study Presented at ASCO -, COLLEGEVILLE, ... Wyeth (NYSE: WYE ), today announced results,of ... patients with relapsed,and/or refractory mantle cell lymphoma (MCL), ... (mammalian target of rapamycin) inhibitor,TORISEL(R) (temsirolimus) experienced a ...
Cached Medicine Technology:Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6
(Date:7/29/2015)... ... July 29, 2015 , ... More than ... service providers of children living with autism will converge upon Penn State to ... , The National Autism Conference will be held Aug. 3-6 at the ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business on ... directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same gene, ... the National academy of Sciences, and has given researchers inklings to explore Rsu1 in ...
(Date:7/29/2015)... ... 2015 , ... With a new community program in the ... Support Services and announced a new charity campaign to raise funds to support ... workshops and educational programs at no charge. Scott Campbell Agency initiates this ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic ... treatments to qualifying patients with demonstrated financial need. , “We are thrilled for ...
Breaking Medicine News(10 mins):Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... collaborative team of researchers spearheaded by Dennis Carson M.D., professor ... UCSD Cancer Center at the University of California, San Diego ... a toxic blue-green algae found in the South Pacific. ... paper that will be published online in Proceedings of the ...
... leader in radiology and medical image and information management,solutions, today announced it ... ended December 31, 2007, before the,market opens on Friday, February 29, 2008., ... -- Friday, ... -- Call begins promptly at 8:30 a.m. (Eastern Time), 7:30 a.m. ...
... Finding could lead to less controversial method of treating ... scientists say they,ve reprogrammed human skin cells into ones ... a breakthrough that could aid in treating many diseases ... the ability to become every cell type found in ...
... an Integral Part of MedCath,s Growth Plans, CHARLOTTE, ... and its physician partners today announced plans to double,the ... Antonio, Texas,creating a 120-bed acute care and heart hospital., ... of shelled,space into 60 inpatient beds, which will be ...
... of acute coronary events such as heart attack in adults ... Italy, researchers reported in Circulation: Journal of the American Heart ... the city for five years preceding a public smoking ban ... found an 11.2 percent reduction of acute coronary events in ...
... physicians specializing in geriatrics, internal or family medicine or ... with heart failure are at risk of dying, new ... to determine whether patients are within six months of ... decisions such as therapeutic approaches and referral for palliative ...
Cached Medicine News:Health News:UCSD research team identifies novel anticancer drug from the sea 2Health News:AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 2Health News:Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells 3Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 2Health News:MedCath Plans 60-bed Expansion at TexSAn Heart Hospital 3Health News:Acute coronary events decreased after public smoking ban in Italy 2Health News:Acute coronary events decreased after public smoking ban in Italy 3Health News:Doctors uncertain about approaches to care for heart failure patients, SLU study finds 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: